CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.
about
CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for NeuroprotectionMicroglia Ontology and SignalingG Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRsAlzheimer's Disease: Mechanism and Approach to Cell TherapyThe Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseFractalkine Signaling and Microglia Functions in the Developing BrainFrom development to dysfunction: microglia and the complement cascade in CNS homeostasisNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptorsChemokine receptor CXCR2: physiology regulator and neuroinflammation controller?Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.Microglia development and functionIVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathologyMicroglia communication: Parallels between aging and Alzheimer's diseaseThe ischemic environment drives microglia and macrophage functionNeuroinflammation in Alzheimer's diseaseSerum and cerebrospinal fluid immune mediators in children with autistic disorder: a longitudinal studyChronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signalingCentral Nervous System: (Immunological) Ivory Tower or Not?Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.Microglia as a critical player in both developmental and late-life CNS pathologies.Old Maids: Aging and Its Impact on Microglia Function.A novel method for gathering and prioritizing disease candidate genes based on construction of a set of disease-related MeSH® terms.Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional rolesModulating neurotoxicity through CX3CL1/CX3CR1 signaling.SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β.Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-SynucleinopathyThe evolving biology of microglia in Alzheimer's disease.Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis.The biphasic role of microglia in Alzheimer's disease.Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injuryFractalkine signaling in regulation of insulin secretion.When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke.Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in miceDisruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.Microglial malfunction: the third rail in the development of Alzheimer's disease.
P2860
Q26739374-7AAD0722-D5E7-4751-9D4F-C1E7278B89BCQ26742077-89E89EAB-54CB-4293-AFAB-E31D54C7B9FFQ26752403-287328A0-A2DB-4953-87F3-E3F950CB0D1DQ26778149-646D1AFB-68E7-489B-ABEF-9DC58C58716AQ26781815-9BDFA65A-6EFF-48C4-8F44-9EF4681FD246Q26782935-BE36F201-9DC7-4C9A-BC92-EDABC5F4A9A5Q26865892-5F4EC091-CFB3-42D1-868F-43089F13A007Q26995483-2B33AFB8-BC02-404A-9C27-C4C55907A0EDQ27007078-ADB93125-CF1C-447F-8673-A4BEB0EDA359Q27303769-74C916F0-1950-483A-A2F2-FBD1B75505C0Q27316453-013755C9-8F03-4FD4-BF37-3F54FB610DDCQ27497796-D3BBC2DF-C89E-4BDC-AF4F-8F356A804D22Q28074099-0469D442-BA4B-4FA7-9FC4-343EEA917C11Q28086874-76B5B7A9-330B-4B57-9742-6B8044FFCE96Q28259238-AFEFC4E6-A699-41CA-8321-A7A982F45A02Q28397818-54DE3BEE-C4A4-44B0-BBFA-43AEEFEE190DQ28567803-A637378C-7EF8-4326-8E56-19AE4BC46F57Q30276375-08A9BDCF-3D46-40AD-BD7D-D40FC9DC2699Q30360306-C3B346AC-4DC7-407A-ACBA-FDE5DCC7E62EQ30411278-CAD2AD5A-7C99-48A6-AB94-0D8D2B36DBF5Q33624540-00FA8F22-8FCB-457F-B0CA-714B2A06BFEDQ33797137-7C061DF3-3770-497D-B24F-F3CC688A6C83Q33834046-D925B087-E0DD-4CA2-BC01-075A1B3E0790Q34002086-44FEC543-3973-4A20-9750-4ACF6CD88823Q34019783-F389DCBF-949D-45E7-BF38-6E2E7D2B8A44Q34946464-9FDB28E5-8AB0-47C0-9292-C89EC3B97163Q34998538-A178A908-9848-4A2F-8366-82F292A39C47Q35019131-A164AB40-7AD5-412B-A6F4-45A51072AD8EQ35064995-EAB8F181-B769-4389-81DF-75B019761A85Q35650827-73D24108-92CA-4DDB-BFF1-6BDEFED78B2AQ35808359-0CCDAAC2-FDFD-407C-8F24-24EBE6D3190FQ35810427-77C2C7C7-7A56-4BED-9A6B-620A76BAC1C7Q35978959-03C3288B-0CDA-4067-AA31-8E690EB83C76Q36020203-0049C4E7-FA4E-46A2-A763-BBCE8F0A9A61Q36121992-12295A94-5F4C-4723-806A-470C0984B82EQ36188164-9887E2DF-AC3A-4C04-B643-4A504EF9BAEFQ36195292-2B9989EB-A50A-45FF-A6F3-CD8B171C3852Q36268050-0C9997B4-9FB9-465A-97D5-879F57E2A0CFQ36271043-3C6CAE89-18DE-45A2-9247-88965EC19EB9Q36348184-41D91575-F71E-4459-B056-DB349110C423
P2860
CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@ast
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@en
type
label
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@ast
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@en
prefLabel
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@ast
CX3CR1 protein signaling modul ...... se model of Alzheimer disease.
@en
P2093
P2860
P50
P356
P1476
CX3CR1 protein signaling modul ...... use model of Alzheimer disease
@en
P2093
Brian Halabisky
Richard M Ransohoff
Seo-Hyun Cho
Yungui Zhou
P2860
P304
32713-32722
P356
10.1074/JBC.M111.254268
P407
P577
2011-07-19T00:00:00Z